Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IGHG4: innovative diagnostic biomarkers for iron overload in β-thalassemia patients. | Hematology | 2025 | 39676317 | PubTator, text mining | PubMed |
| Underappreciated layers of antibody-mediated immune synapse architecture and dynamics. | mBio | 2025 | 39660921 | PubTator, text mining | PubMed |
| Divergent changes in complement pathway gene expression in schizophrenia and bipolar disorder: Links to inflammation and neurogenesis in the subependymal zone. | Schizophr Res | 2025 | 39616737 | PubTator, text mining | PubMed |
| Association between coagulation activity and clinical and imaging outcomes in acute ischemic stroke patients - A sub-study of the MR CLEAN NO-IV trial. | Thromb Res | 2025 | 39571223 | PubTator, text mining | PubMed |
| Correspondence to editorial on "DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease". | Clin Mol Hepatol | 2025 | 39253743 | PubTator, text mining | PubMed |
A complement to epigenetics in metabolic dysfunction-associated steatotic liver disease: Editorial on "DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease". | Clin Mol Hepatol | 2025 | 39188228 | PubTator, text mining | PubMed |
| Region-Specific Transcriptional Signatures of Brain Aging in the Absence of Neuropathology at the Single-cell Level. | bioRxiv | 2025 | 37577533 | PubTator, text mining | PubMed |
| The assessment of the relationship between the development of cardiovascular diseases and SCUBE-1 level in individuals exposed to loud noise. | Medicine (Baltimore) | 2024 | 39705419 | PubTator, text mining | PubMed |
| [Maggot alleviates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting immune stress and complement activation]. | Nan Fang Yi Ke Da Xue Xue Bao | 2024 | 39623267 | PubTator, text mining | PubMed |
| Africanized honeybee venom (Apis mellifera) promotes human complement activation split products storm. | Front Immunol | 2024 | 39606222 | PubTator, text mining | PubMed |
| [Study on serum proteomic characteristics of workers with rare earth samarium oxide pneumoconiosis]. | Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi | 2024 | 39604234 | PubTator, text mining | PubMed |
| Maternal Serum SCUBE-1: A Novel Ischemic Marker in Preeclampsia. | J Pers Med | 2024 | 39590594 | PubTator, text mining | PubMed |
| Downhill running does not alter blood C1q availability or complement-dependent cytotoxicity of therapeutic monoclonal antibodies against haematological cancer cell lines in vitro. | Sci Rep | 2024 | 39548231 | PubTator, text mining | PubMed |
| Complement C1S is a potential prognostic biomarker and associated with M2 macrophage infiltration in gliomas: From bioinformatics to comprehensive experimental validation. | Int Immunopharmacol | 2024 | 39515040 | PubTator, text mining | PubMed |
| Comprehensive single-cell and bulk transcriptomic analyses to develop an NK cell-derived gene signature for prognostic assessment and precision medicine in breast cancer. | Front Immunol | 2024 | 39507529 | PubTator, text mining | PubMed |
| Torque Teno Virus Control by the Classical Pathway of Complement Activation-A Retrospective Analysis From a First-in-Human Trial Utilizing Sutimlimab. | J Med Virol | 2024 | 39503157 | PubTator, text mining | PubMed |
| Autoimmune haemolytic anaemias. | Nat Rev Dis Primers | 2024 | 39487134 | PubTator, text mining | PubMed |
| Novel prognostic model of complement and coagulation cascade-related genes correlates with immune environment and drug sensitivity in hepatocellular carcinoma. | Heliyon | 2024 | 39391504 | PubTator, text mining | PubMed |
| Protein biomarkers in assessing kidney quality before transplantation‑current status and future perspectives (Review). | Int J Mol Med | 2024 | 39370783 | PubTator, text mining | PubMed |
| [New drugs for the treatment of primary immune thrombocytopenia]. | Rinsho Ketsueki | 2024 | 39358266 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=7